durvalumab,pembrolizumab,pemetrexed,cisplatin,gemcitabine
astrazeneca,merck
['imfinzi', 'keytruda', 'nsclc', 'sclc', 'astrazeneca']
asco: keytruda scores phase iii nsclc win, outperforms astrazeneca s imfinzi 
BioCalifornia is committed to the growth of life sciences, and commercialization of discoveries to improve human health, the environment, and sustainability.